HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diffuse Palmoplantar Keratoderma (Tylosis)

An autosomal dominant disorder characterized by a widely distributed, well-demarcated hyperkeratosis of the palms and soles. There is more than one genotypically distinct form, each of which is clinically similar but histologically distinguishable. Diffuse palmoplantar keratoderma is distinct from palmoplantar keratoderma (KERATODERMA, PALMOPLANTAR), as the former exhibits autosomal dominant inheritance and hyperhidrosis is frequently present.
Also Known As:
Tylosis; Keratoderma, Palmoplantar, Diffuse; Keratosis Palmaris et Plantaris Familiaris; Syndrome, Thost-Unna; Syndrome, Unna-Thost; Thost Unna Syndrome; Unna Thost Syndrome; Thost-Unna Syndrome; Unna-Thost Syndrome
Networked: 35 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Esophageal Achalasia (Megaesophagus)
3. Pathologic Constriction (Stenosis)
4. Barrett Esophagus (Barrett's Esophagus)
5. Plummer-Vinson Syndrome (Syndrome, Plummer-Vinson)

Experts

1. Kelsell, David P: 3 articles (01/2017 - 06/2010)
2. McRonald, Fiona E: 3 articles (01/2012 - 04/2006)
3. Risk, Janet M: 3 articles (01/2012 - 04/2006)
4. Hosur, Vishnu: 2 articles (11/2017 - 08/2017)
5. Shultz, Leonard D: 2 articles (11/2017 - 08/2017)
6. Brooke, Matthew A: 2 articles (01/2017 - 08/2014)
7. Ishida-Yamamoto, Akemi: 2 articles (01/2017 - 08/2014)
8. Field, John K: 2 articles (07/2006 - 04/2006)
9. Liloglou, Triantafillos: 2 articles (07/2006 - 04/2006)
10. Xinarianos, George: 2 articles (07/2006 - 04/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Diffuse Palmoplantar Keratoderma:
1. FertilizersIBA
2. CausticsIBA
3. CytoglobinIBA
4. AmphiregulinIBA
5. Keratin-1IBA
6. LyeIBA
7. envoplakinIBA
8. ErbB Receptors (EGF Receptor)IBA
9. Keratin-9 (Keratin 9)IBA
10. Type II Keratins (Type II Keratin)IBA

Therapies and Procedures

1. Slit Lamp
2. Transjugular Intrahepatic Portasystemic Shunt
3. Therapeutics